Alison B. Durham

2.6k total citations · 1 hit paper
30 papers, 1.5k citations indexed

About

Alison B. Durham is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Alison B. Durham has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Alison B. Durham's work include Cutaneous Melanoma Detection and Management (13 papers), Nonmelanoma Skin Cancer Studies (10 papers) and Melanoma and MAPK Pathways (5 papers). Alison B. Durham is often cited by papers focused on Cutaneous Melanoma Detection and Management (13 papers), Nonmelanoma Skin Cancer Studies (10 papers) and Melanoma and MAPK Pathways (5 papers). Alison B. Durham collaborates with scholars based in United States, Belgium and France. Alison B. Durham's co-authors include Zhimin Gu, Evann C. Mitchell, Thomas P. Mathews, Alpaslan Tasdogan, Bo Shen, Misty S. Martin-Sandoval, Michael L. McCormick, Zhiyu Zhao, Jessalyn M. Ubellacker and Douglas R. Spitz and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alison B. Durham

29 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymph protects metastasizing melanoma cells from ferroptosis

2020 625 citations Jessalyn M. Ubellacker, Alpaslan Tasdogan et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison B. Durham United States	15	915	554	422	343	294	30	1.5k
Bizhan Bandarchi Canada	14	440 0.5×	422 0.8×	214 0.5×	202 0.6×	52 0.2×	19	929
Ursula E. Lang United States	13	1.3k 1.4×	549 1.0×	471 1.1×	151 0.4×	69 0.2×	31	1.8k
You Hong Fan United States	13	793 0.9×	841 1.5×	291 0.7×	227 0.7×	83 0.3×	25	1.7k
Kathryn E. Yost United States	15	1.1k 1.2×	1.1k 2.1×	444 1.1×	113 0.3×	155 0.5×	21	2.3k
Roberto Patuzzo Italy	20	389 0.4×	957 1.7×	104 0.2×	110 0.3×	303 1.0×	56	1.3k
Francesca M. Bosisio Belgium	20	392 0.4×	330 0.6×	163 0.4×	77 0.2×	104 0.4×	53	972
Blake T. Aftab United States	18	839 0.9×	676 1.2×	106 0.3×	77 0.2×	188 0.6×	38	1.6k
Lauren G. Aoude Australia	16	634 0.7×	434 0.8×	287 0.7×	86 0.3×	47 0.2×	29	1.0k
Susanna Virolainen Finland	18	280 0.3×	288 0.5×	174 0.4×	74 0.2×	99 0.3×	25	730
Viswanathan Muthusamy United States	17	996 1.1×	483 0.9×	208 0.5×	64 0.2×	58 0.2×	28	1.4k

Countries citing papers authored by Alison B. Durham

Since Specialization

Citations

This map shows the geographic impact of Alison B. Durham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison B. Durham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison B. Durham more than expected).

Fields of papers citing papers by Alison B. Durham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison B. Durham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison B. Durham. The network helps show where Alison B. Durham may publish in the future.

Co-authorship network of co-authors of Alison B. Durham

This figure shows the co-authorship network connecting the top 25 collaborators of Alison B. Durham. A scholar is included among the top collaborators of Alison B. Durham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison B. Durham. Alison B. Durham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pedersen, Elisabeth A., Paul W. Harms, Lili Zhao, et al.. (2022). Polypoid melanoma is associated with aggressive histopathological characteristics and poor clinical prognosis: A retrospective cohort study. Journal of the American Academy of Dermatology. 88(5). 1169–1170.

Kang, Yoon‐Tae, Shamileh Fouladdel, Vasudha Murlidhar, et al.. (2022). Isolation of Circulating Tumor Cells to Diagnose Melanoma and Evaluate the Efficacy of Surgical Resection Using Melanoma‐Specific Microsystem. SHILAP Revista de lepidopterología. 2(8). 9 indexed citations

Kahana, Alon, Chris Andrews, May P. Chan, et al.. (2021). Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial. The Oncologist. 26(7). e1240–e1249. 21 indexed citations

Potu, Harish, Malathi Kandarpa, Luke F. Peterson, et al.. (2021). Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma. Oncotarget. 12(3). 160–172. 11 indexed citations

Al‐Omari, Ahmed, Michael D. Carter, Paul W. Harms, et al.. (2020). DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approach. Modern Pathology. 33(7). 1307–1317. 21 indexed citations

Ubellacker, Jessalyn M., Alpaslan Tasdogan, Vijayashree Ramesh, et al.. (2020). Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 585(7823). 113–118. 625 indexed citations breakdown →

Rizzo, Jason M., et al.. (2020). Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series. JAAD Case Reports. 8. 19–22. 7 indexed citations

Chan, May P., Chia‐Jen Liu, Nallasivam Palanisamy, et al.. (2019). Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas. Modern Pathology. 33(6). 1092–1103. 20 indexed citations

Yalamanchi, Pratyusha, Kevin J. Kovatch, Joshua D. Smith, et al.. (2019). Cranial nerve outcomes in regionally recurrent head & neck melanoma after sentinel lymph node biopsy. The Laryngoscope. 130(7). 1707–1714. 4 indexed citations

10.

Wang, Min, Kelly L. Harms, Alison B. Durham, et al.. (2018). Subungual atypical lentiginous melanocytic proliferations in children and adolescents: A clinicopathologic study. Journal of the American Academy of Dermatology. 79(2). 327–336.e2. 21 indexed citations

11.

Carter, Michael D., Alison B. Durham, Paul W. Harms, et al.. (2018). Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH. Human Pathology. 86. 115–123. 16 indexed citations

12.

Rizzo, Jason M., Leslie A. Fecher, May P. Chan, & Alison B. Durham. (2018). Metastatic melanoma with diffuse melanosis histologically after stable response to talimogene laherparepvec therapy. JAAD Case Reports. 4(4). 379–381. 1 indexed citations

13.

Bailey, Kelly M., Alison B. Durham, Lili Zhao, et al.. (2018). Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysis. Translational Pediatrics. 7(3). 203–210. 9 indexed citations

14.

Lee, Jay, Alison B. Durham, Christopher K. Bichakjian, et al.. (2018). Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma. Annals of Surgical Oncology. 26(2). 386–394. 33 indexed citations

15.

Wang, Lisha, Paul W. Harms, Nallasivam Palanisamy, et al.. (2017). Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA In Situ Hybridization Assay. Clinical Cancer Research. 23(18). 5622–5630. 26 indexed citations

16.

Potu, Harish, Luke F. Peterson, Malathi Kandarpa, et al.. (2017). Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications. 8(1). 14449–14449. 53 indexed citations

17.

Chan, May P., Aleodor A. Andea, Paul W. Harms, et al.. (2016). Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus. Modern Pathology. 29(3). 227–239. 32 indexed citations

18.

Sharpe, Hayley J., Grégoire Pau, Gerrit J.P. Dijkgraaf, et al.. (2015). Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma. Cancer Cell. 27(3). 327–341. 296 indexed citations

19.

Durham, Alison B. & Sandra L. Wong. (2014). Sentinel Lymph Node Biopsy in Melanoma: Controversies and Current Guidelines. Future Oncology. 10(3). 429–442. 9 indexed citations

20.

Durham, Alison B. & Jeffrey S. Orringer. (2012). Q-Switched Laser Therapy for Recalcitrant and Recurrent Pigmentation After Chemical Depigmentation for Extensive Vitiligo. Dermatologic Surgery. 38(9). 1563–1565. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact